Literature DB >> 19346317

Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate.

Sumit Bhattacharyya1, Kemal Solakyildirim, Zhenqing Zhang, Mei Ling Chen, Robert J Linhardt, Joanne K Tobacman.   

Abstract

The chemokine IL-8 is critically important in inflammatory processes in human tissues, and IL-8 interactions with sulfated glycosaminoglycans have been implicated in modification of inflammatory responses in bronchial epithelium. To determine the role of chondroitin-4-sulfate (C4S) in mediating effects of IL-8, we silenced the enzyme N-acetylgalactosamine-4-sulfatase (arylsulfatase B [ASB]) that removes the 4-sulfate group from C4S, in the IB3-1 and C38 bronchial epithelial cell lines and in normal primary bronchial epithelial cells. When ASB was silenced and IL-8 production stimulated by exposure to TNF-alpha, ASB activity declined by roughly 75%, cellular C4S content increased by over 7.5 microg/mg protein, cell-bound IL-8 increased by over 530 pg/mg protein, and secreted IL-8 declined by over 520 pg/mg protein in all cell lines (P < 0.001). When cell lysates were immunoprecipitated with C4S antibody after ASB silencing and TNF-alpha, the IL-8 content of the immunoprecipitate was approximately 500 pg/mg protein, indicating that most of the cell-bound IL-8 was associated with C4S. Cell fractionation demonstrated that the IL-8 content associated with the cell membranes was about twice that of the cytosolic fraction. Also, ASB appeared to localize in the cell membrane, as well as in lysosomes. Neutrophil attraction to the cell lysates increased after ASB silencing, consistent with increased attraction to the cell-bound IL-8. These findings provide evidence for the influential role of ASB and C4S in the regulation of IL-8 secretion, and suggest that changes in ASB activity and C4S content may have a significant impact on IL-8-mediated inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346317     DOI: 10.1165/rcmb.2008-0482OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  18 in total

1.  Decline in arylsulfatase B and Increase in chondroitin 4-sulfotransferase combine to increase chondroitin 4-sulfate in traumatic brain injury.

Authors:  Sumit Bhattacharyya; Xiaolu Zhang; Leo Feferman; David Johnson; Frank C Tortella; Marina Guizzetti; Joanne K Tobacman
Journal:  J Neurochem       Date:  2015-06-28       Impact factor: 5.372

2.  Extra-lysosomal localization of arylsulfatase B in human colonic epithelium.

Authors:  Sanjiv V Prabhu; Sumit Bhattacharyya; Grace Guzman-Hartman; Virgilia Macias; André Kajdacsy-Balla; Joanne K Tobacman
Journal:  J Histochem Cytochem       Date:  2011-01-11       Impact factor: 2.479

3.  Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol.

Authors:  Xiaolu Zhang; Sumit Bhattacharyya; Handojo Kusumo; Charles R Goodlett; Joanne K Tobacman; Marina Guizzetti
Journal:  Glia       Date:  2013-12-06       Impact factor: 7.452

4.  Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients.

Authors:  Girish Sharma; Jenifer Burke; Sumit Bhattacharyya; Neha Sharma; Shivani Katyal; R Lucy Park; Joanne Tobacman
Journal:  Pediatr Pulmonol       Date:  2012-05-01

5.  Exposure to common food additive carrageenan leads to reduced sulfatase activity and increase in sulfated glycosaminoglycans in human epithelial cells.

Authors:  Bo Yang; Sumit Bhattacharyya; Robert Linhardt; Joanne Tobacman
Journal:  Biochimie       Date:  2012-03-05       Impact factor: 4.079

6.  Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A.

Authors:  Sumit Bhattacharyya; Leo Feferman; Joanne K Tobacman
Journal:  Biochim Biophys Acta       Date:  2014-12-12

7.  E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.

Authors:  Zhenyu Wang; Mellisa Ly; Fuming Zhang; Weihong Zhong; Amy Suen; Anne Marie Hickey; Jonathan S Dordick; Robert J Linhardt
Journal:  Biotechnol Bioeng       Date:  2010-12-15       Impact factor: 4.530

8.  Impact of salt exposure on N-acetylgalactosamine-4-sulfatase (arylsulfatase B) activity, glycosaminoglycans, kininogen, and bradykinin.

Authors:  Kumar Kotlo; Sumit Bhattacharyya; Bo Yang; Leonid Feferman; Shah Tejaskumar; Robert Linhardt; Robert Danziger; Joanne K Tobacman
Journal:  Glycoconj J       Date:  2013-02-06       Impact factor: 2.916

Review 9.  Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.

Authors:  Emer P Reeves; Kevin Molloy; Kerstin Pohl; Noel G McElvaney
Journal:  ScientificWorldJournal       Date:  2012-05-03

10.  Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: implications for mechanisms of action and resistance.

Authors:  Sumit Bhattacharyya; Kemal Solakyildirim; Zhenqing Zhang; Robert J Linhardt; Joanne K Tobacman
Journal:  Malar J       Date:  2009-12-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.